Bedel Financial Consulting’s Opus Genetics, Inc. Common Stock IRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.1K | Hold |
15,000
| – | – | ﹤0.01% | 272 |
|
|
2025
Q1 | $14K | Hold |
15,000
| – | – | ﹤0.01% | 259 |
|
|
2024
Q4 | $18.2K | Hold |
15,000
| – | – | ﹤0.01% | 265 |
|
|
2024
Q3 | $19.7K | Hold |
15,000
| – | – | ﹤0.01% | 258 |
|
|
2024
Q2 | $23K | Hold |
15,000
| – | – | ﹤0.01% | 250 |
|
|
2024
Q1 | $30.2K | Hold |
15,000
| – | – | ﹤0.01% | 252 |
|
|
2023
Q4 | $45.2K | Hold |
15,000
| – | – | 0.01% | 241 |
|
|
2023
Q3 | $50.3K | Hold |
15,000
| – | – | 0.01% | 232 |
|
|
2023
Q2 | $65.1K | Hold |
15,000
| – | – | 0.01% | 237 |
|
|
2023
Q1 | $56.3K | Hold |
15,000
| – | – | 0.01% | 225 |
|
|
2022
Q4 | $53K | Hold |
15,000
| – | – | 0.01% | 226 |
|
|
2022
Q3 | $31K | Buy |
+15,000
| New | +$31K | 0.01% | 212 |
|